James Murphy

James Murphy

Director of Finance/CFO chez MUSTANG BIO, INC.

67 ans
Health Technology
Consumer Services
Producer Manufacturing

Profil

James B.
Murphy
is currently the Chief Financial & Accounting Officer at Mustang Bio, Inc. He previously worked as a Controller at Sumitomo Pharma America, Inc. from 1990 to 1994, as the Chief Financial Officer & Senior VP-Administration at HMSR, Inc. from 1994 to 2001, as the Vice President-Finance at Whatman, Inc. from 2001 to 2003, as the Vice President & Chief Financial Officer at Oncotelic Therapeutics, Inc. from 2004 to 2012, and as the Chief Financial Officer, Secretary & Treasurer at GI Dynamics, Inc. from 2016 to 2017.
He also briefly served as the Chief Financial & Accounting Officer at Decibel Therapeutics, Inc. from 2022 to 2023.
Mr. Murphy received his undergraduate degree from the College of the Holy Cross (Massachusetts).

Postes actifs de James Murphy

SociétésPosteDébut
MUSTANG BIO, INC. Director of Finance/CFO 19/01/2024
Tous les postes actifs de James Murphy

Anciens postes connus de James Murphy

SociétésPosteFin
DECIBEL THERAPEUTICS, INC. Director of Finance/CFO 22/09/2023
GI DYNAMICS, INC. Director of Finance/CFO 01/12/2017
ONCOTELIC THERAPEUTICS, INC. Director of Finance/CFO 31/03/2012
Director of Finance/CFO 01/05/2003
Director of Finance/CFO 01/01/2001
Voir l'expérience en détail de James Murphy

Formation de James Murphy

College of the Holy Cross (Massachusetts) Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Murphy

Relations

75

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
ONCOTELIC THERAPEUTICS, INC.

Health Technology

DECIBEL THERAPEUTICS, INC.

Health Technology

MUSTANG BIO, INC.

Health Technology

Entreprise privées4

Health Technology

Health Technology

Health Technology

Producer Manufacturing

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James Murphy